NYSE:ZEPP Zepp Health (ZEPP) Stock Price, News & Analysis → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free ZEPP Stock Alerts $1.01 -0.02 (-1.94%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.99▼$1.0650-Day Range$0.92▼$1.6052-Week Range$0.90▼$2.10Volume56,957 shsAverage Volume87,979 shsMarket Capitalization$61.94 millionP/E RatioN/ADividend YieldN/APrice Target$4.96 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Zepp Health alerts: Email Address Zepp Health MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside391.1% Upside$4.96 Price TargetShort InterestHealthy0.00% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.34Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.17 out of 5 starsMedical Sector434th out of 939 stocksElectronic Computers Industry4th out of 6 stocks 3.5 Analyst's Opinion Consensus RatingZepp Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.96, Zepp Health has a forecasted upside of 391.1% from its current price of $1.01.Amount of Analyst CoverageZepp Health has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.00% of the outstanding shares of Zepp Health have been sold short.Short Interest Ratio / Days to CoverZepp Health has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Zepp Health has recently decreased by 46.34%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldZepp Health does not currently pay a dividend.Dividend GrowthZepp Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ZEPP. Previous Next 1.9 News and Social Media Coverage News SentimentZepp Health has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Zepp Health this week, compared to 1 article on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Zepp Health insiders have not sold or bought any company stock.Percentage Held by Insiders36.00% of the stock of Zepp Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.61% of the stock of Zepp Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Zepp Health is -2.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Zepp Health is -2.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioZepp Health has a P/B Ratio of 0.18. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> About Zepp Health Stock (NYSE:ZEPP)Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. It operates through two segments, Self-Branded Products and Others and Xiaomi Wearable Products. The company offers smart bands, watches, and scales; and associated accessories, smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.Read More ZEPP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ZEPP Stock News HeadlinesMarch 28, 2024 | msn.comXiaomi’s Smart Band 8 Pro is a cheap and easy way to track health, control media and get notifications in an Apple Watch-style designMarch 27, 2024 | prnewswire.comZepp Health to Honor Marathon Icon Kelvin Kiptum with Amazfit Cheetah Pro Commemorative Edition Watch and Foundation SupportMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.March 27, 2024 | americanbankingnews.comZepp Health (NYSE:ZEPP) Given a $4.96 Price Target at Fundamental ResearchMarch 24, 2024 | uk.finance.yahoo.comZepp Health Full Year 2023 Earnings: Misses ExpectationsMarch 20, 2024 | seekingalpha.comZepp Health Corporation (ZEPP) Q4 2023 Earnings Call TranscriptMarch 20, 2024 | investing.comZepp Health earnings missed by ¥1.34, revenue fell short of estimatesMarch 19, 2024 | finance.yahoo.comQ4 2023 Zepp Health Corp Earnings CallMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.March 19, 2024 | seekingalpha.comOTRK, STRC and APM among mid-day moversMarch 19, 2024 | finance.yahoo.comZepp Health Corporation (NYSE:ZEPP) Q4 2023 Earnings Call TranscriptMarch 19, 2024 | finanznachrichten.deZepp Health Corp.: Zepp Health Corporation Reports Fourth Quarter and Full Year 2023 Unaudited Financial ResultsMarch 18, 2024 | investorplace.comZEPP Stock Earnings: Zepp Health Misses EPS, Misses Revenue for Q4 2023March 18, 2024 | benzinga.comRecap: Zepp Health Q4 EarningsMarch 18, 2024 | prnewswire.comZepp Health Corporation Reports Fourth Quarter and Full Year 2023 Unaudited Financial ResultsMarch 15, 2024 | benzinga.comA Preview Of Zepp Health's EarningsMarch 9, 2024 | investing.comZepp Health Corp (ZEPP)March 7, 2024 | finance.yahoo.comZepp Health Corporation to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024March 1, 2024 | msn.comMakers of Amazfit smartwatches introduce new over the counter hearing aidsFebruary 26, 2024 | msn.comZepp Health launches Zepp OS 3.5 with AI-powered Zepp FlowFebruary 25, 2024 | prnewswire.comZepp Health Unveils Zepp OS 3.5 with Zepp Flow™, Powered by Large Language Model AI, Pioneering the Next Generation of Wearable Intelligence Devices at MWC Barcelona 2024February 25, 2024 | benzinga.comZepp Health Stock (NYSE:ZEPP), Short Interest ReportFebruary 23, 2024 | msn.comAmazfit Active Edge Rugged Smartwatch Launched: Specifications, Price, ColoursFebruary 17, 2024 | finance.yahoo.comZEPP Sep 2024 5.000 callFebruary 17, 2024 | finance.yahoo.comZEPP Jun 2024 2.500 putFebruary 6, 2024 | msn.comThis software update gives your Amazfit watch new AI-powered voice controlsFebruary 5, 2024 | msn.comBest smartwatches for fitness in 2024See More Headlines Receive ZEPP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zepp Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/20/2023Today3/28/2024Next Earnings (Estimated)5/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Electronic computers Sub-IndustryN/A Current SymbolNYSE:ZEPP CUSIPN/A CIK1720446 Webwww.huami.com Phone861059403268FaxN/AEmployees987Year FoundedN/APrice Target and Rating Average Stock Price Target$4.96 High Stock Price Target$4.96 Low Stock Price Target$4.96 Potential Upside/Downside+391.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,880,000.00 Net Margins-8.66% Pretax Margin-9.49% Return on Equity-8.55% Return on Assets-4.51% Debt Debt-to-Equity Ratio0.34 Current Ratio2.04 Quick Ratio1.49 Sales & Book Value Annual Sales$2.97 billion Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book Value$5.75 per share Price / Book0.18Miscellaneous Outstanding Shares61,335,000Free Float39,254,000Market Cap$61.95 million OptionableOptionable Beta0.81 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Wang Huang (Age 47)Founder, Chairman & CEO Mr. Leon Cheng Deng (Age 41)Chief Financial Officer Mr. Mike Yan Yeung (Age 52)Chief Operating Officer Mr. Meihui Fan (Age 45)Chief Technology Officer Ms. Grace Yujia ZhangDirector of Investor RelationsMr. Pengtao Yu (Age 42)Chief Industrial Designer Dr. Ramesh Jain Ph.D.Chief Technical Advisor of Huami AI Research InstituteMore ExecutivesKey CompetitorsBionano GenomicsNASDAQ:BNGOVicarious SurgicalNYSE:RBOTRegulus TherapeuticsNASDAQ:RGLSAVROBIONASDAQ:AVROCarmellNASDAQ:CTCXView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 23,380 shares on 2/26/2024Ownership: 0.038%Citadel Advisors LLCSold 200 shares on 2/15/2024Ownership: 0.000%Allspring Global Investments Holdings LLCSold 129,476 shares on 1/25/2024Ownership: 8.160%View All Institutional Transactions ZEPP Stock Analysis - Frequently Asked Questions Should I buy or sell Zepp Health stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zepp Health in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ZEPP shares. View ZEPP analyst ratings or view top-rated stocks. What is Zepp Health's stock price target for 2024? 1 brokers have issued 12-month price objectives for Zepp Health's stock. Their ZEPP share price targets range from $4.96 to $4.96. On average, they expect the company's share price to reach $4.96 in the next year. This suggests a possible upside of 391.1% from the stock's current price. View analysts price targets for ZEPP or view top-rated stocks among Wall Street analysts. How have ZEPP shares performed in 2024? Zepp Health's stock was trading at $1.42 at the start of the year. Since then, ZEPP shares have decreased by 28.9% and is now trading at $1.01. View the best growth stocks for 2024 here. Are investors shorting Zepp Health? Zepp Health saw a decline in short interest in March. As of March 15th, there was short interest totaling 2,200 shares, a decline of 46.3% from the February 29th total of 4,100 shares. Based on an average trading volume of 72,400 shares, the short-interest ratio is presently 0.0 days. View Zepp Health's Short Interest. When is Zepp Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024. View our ZEPP earnings forecast. How were Zepp Health's earnings last quarter? Zepp Health Co. (NYSE:ZEPP) issued its earnings results on Monday, November, 20th. The company reported $0.01 EPS for the quarter, missing analysts' consensus estimates of $0.73 by $0.72. The company earned $82.53 million during the quarter. Zepp Health had a negative trailing twelve-month return on equity of 8.55% and a negative net margin of 8.66%. What guidance has Zepp Health issued on next quarter's earnings? Zepp Health issued an update on its first quarter 2024 earnings guidance on Monday, March, 18th. The company provided EPS guidance of for the period. The company issued revenue guidance of $42.0 million-$49.0 million, compared to the consensus revenue estimate of $72.6 million. Who are Zepp Health's major shareholders? Zepp Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (8.16%), Virtu Financial LLC (0.04%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). How do I buy shares of Zepp Health? Shares of ZEPP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:ZEPP) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingFed launches fourth dollar overhaulStansberry ResearchMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zepp Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.